Jeff Galvin, CEO of American Gene Technologies, shares his journey from Silicon Valley to biotech and the future of gene therapy. Watch the interview on Bio Blast! https://lnkd.in/gVYYv7FX #genetherapy #biotech #innovation
American Gene Technologies? International Inc.
生物技术研究
Rockville,Maryland 3,432 位关注者
Our mission is to leverage the power of gene and cell therapy to reduce human suffering from serious human diseases.
关于我们
American Gene Technologies? International Inc. (AGT?) is a private biotechnology company pursuing cures and treatments for infectious diseases, cancers, and monogenic disorders. AGT?'s emerging gene and cell therapeutics programs are designed to: ? Create immunotherapy for HIV disease with gene-modified T cells ? Activate innate T cell immunity capable of killing all tumor cells with its vector used in immuno-oncology ? Treat PKU by bringing a functional gene into cells that express a dysfunctional gene due to mutation ? Advance clinically to provide human proof of concept For over a decade, AGT? has developed, tested, and banked thousands of lentiviral vectors that can be adapted to the specific needs of new target diseases. AGT? has developed gene therapy for diseases using this rapid gene delivery platform. GENE THERAPIES AGT?’s platform allows it to pursue clinical “cures” for complex diseases. The company has developed patent-protected gene therapeutics that are breakthroughs in medicine. *** See our extensive award winning patents on our website *** HIV/AIDS Immunotherapy for HIV disease with gene-modified T cells IMMUNO-ONCOLOGY Activates innate T cell immunity capable of killing all tumor cells with its vector used in immuno-oncology PHENYLKETONURIA (PKU) Treats PKU by bringing a functional gene into cells that express a dysfunctional gene due to mutation AGT?'s Core Objectives ?? Leverage our lentivirus platform to create highly-effective targeted genetic medicines ?? Create solutions for patients across a spectrum of infectious diseases, cancers and inherited disorders ?? Collaborate with leading medical researchers from around the globe To learn more and get in touch with American Gene Technologies? Inc., contact us today at https://www.americangene.com/contact-us/
- 网站
-
https://www.americangene.com/
American Gene Technologies? International Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Rockville,Maryland
- 类型
- 私人持股
- 创立
- 2007
- 领域
- HIV and Hepatitis-C Viral Therapeutics、Cancer Therapeutics、Autosomal Disorders、Immuno-Oncology、Gene Therapy和Cell Therapy
产品
American Gene Technologies
电子处方软件
AGT's focus on immuno-oncology paves a path for rapid drug development and future cures for diseases like HIV/AIDS, PKU, and Liver Cancer.
地点
-
主要
9713 Key West Ave
500
US,Maryland,Rockville,20850
American Gene Technologies? International Inc.员工
-
Jeff Galvin
-
Bill Moher
Advisor, Investor, and Consultant to Early Stage Startups through Enterprise Global 2000 Businesses. Committed Evangelist for AI/ML and Digital…
-
Julia Brown
-
JP Isham
Entertainment Advisory Board at Gala - Games, Film and Music Managing Director Alchemist Investment Fund
动态
-
Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. https://loom.ly/96TZ0jU #HIV #celltherapy #biotech
-
-
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on their research for HIV! https://loom.ly/jAThqIU #HIVResearch #ClinicalTrials
-
-
Can genetic evidence make drugs more effective? A new study in Nature suggests YES. Drug mechanisms with genetic support have a 2.6x higher chance of success. This could change the future of drug development! https://loom.ly/NxSxjXk #genetics #science #healthcare
-
-
Dr. Marcus Conant will be participating in a roundtable on cell and #GeneTherapy alongside Andrew Dietz, MD, of @ShapeTX at this year’s CMO Summit 360 on April 18 at 12:50 PM ET. Learn more: https://loom.ly/EjJavXE #CMO360
-
Exciting news for the future of medicine! The strategic market insight company Nova 1 values the cell & gene therapy market @ $18 billion in 2023 growing at a CAGR of 18% over the next decade. They see a near $100 billion market size by 2033. https://loom.ly/kpuPhu4 #genetherapy #futureofmedicine
-
-
This #NYHAAD, we support @NYHAAD and their mission to create meaningful and intentional spaces for young people to ask questions, learn, and talk about the impacts of HIV and their community. #StopHIVTogether #EndHIVStigma
-
-
Listen in with Dr. Marcus Conant as he discusses #genetherapy for HIV suppression with CGTLive here https://loom.ly/zllWHkQ
-
We are grateful to have Dr. Marcus Conant represent our mission to find a functional cure for #HIV, especially at #CROI2024. Learn about his journey in @PharmaVoice: https://loom.ly/JV88YD0